10x Genomics, Inc. (NASDAQ:TXG – Get Rating) CEO Serge Saxonov sold 2,602 shares of 10x Genomics stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $55.06, for a total transaction of $143,266.12. Following the completion of the transaction, the chief executive officer now owns 893,190 shares in […]
Raymond James cut shares of NeoGenomics (NASDAQ:NEO – Get Rating) from an outperform rating to a market perform rating in a research report report published on Tuesday morning, The Fly reports. A number of other research analysts have also weighed in on NEO. Cowen boosted their target price on NeoGenomics from $14.00 to $20.00 and […]
Barclays initiated coverage on shares of 10x Genomics (NASDAQ:TXG – Get Rating) in a research report issued to clients and investors on Wednesday, The Fly reports. The brokerage set an “overweight” rating and a $65.00 price target on the stock. Barclays‘s price target indicates a potential upside of 23.50% from the stock’s previous close. TXG […]
10x Genomics (NASDAQ:TXG – Get Rating) posted its quarterly earnings results on Wednesday. The company reported ($0.44) EPS for the quarter, missing analysts’ consensus estimates of ($0.38) by ($0.06), Briefing.com reports. The company had revenue of $134.29 million during the quarter, compared to analyst estimates of $128.87 million. 10x Genomics had a negative return on […]
Should You Buy or Sell 10x Genomics Stock? Get The Latest TXG Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.